Hunan Jiudian Pharmaceutical Co Ltd (300705) — Cash Flow-to-Debt Ratio
Hunan Jiudian Pharmaceutical Co Ltd (300705) has a Cash Flow-to-Debt Ratio of 0.18x as of September 2025, meaning its operating cash flow of CN¥180.33 Million could theoretically repay 0% of its total liabilities (CN¥1.02 Billion) in one year. See 300705 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hunan Jiudian Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Hunan Jiudian Pharmaceutical Co Ltd across 12 annual periods. Also explore net asset momentum of Hunan Jiudian Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hunan Jiudian Pharmaceutical Co Ltd (2013–2024)
Year-by-year debt coverage analysis for Hunan Jiudian Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see market value of Hunan Jiudian Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.88x | CN¥746.36 Million | CN¥846.40 Million | ▲ +83.6% |
| 2023 | 0.48x | CN¥431.19 Million | CN¥897.93 Million | ▲ +33.4% |
| 2022 | 0.36x | CN¥268.99 Million | CN¥747.05 Million | ▲ +21.8% |
| 2021 | 0.30x | CN¥190.87 Million | CN¥645.90 Million | ▼ -41.9% |
| 2020 | 0.51x | CN¥149.99 Million | CN¥295.04 Million | ▲ +73.8% |
| 2019 | 0.29x | CN¥90.74 Million | CN¥310.23 Million | ▼ -3.5% |
| 2018 | 0.30x | CN¥68.23 Million | CN¥225.05 Million | ▼ -58.9% |
| 2017 | 0.74x | CN¥80.42 Million | CN¥108.95 Million | ▼ -1.5% |
| 2016 | 0.75x | CN¥55.18 Million | CN¥73.60 Million | ▲ +48.6% |
| 2015 | 0.50x | CN¥32.20 Million | CN¥63.81 Million | ▼ -1.6% |
| 2014 | 0.51x | CN¥30.11 Million | CN¥58.71 Million | ▲ +27.5% |
| 2013 | 0.40x | CN¥30.69 Million | CN¥76.30 Million | — |